Cepheid
Total Raised
$58.45MInvestors Count
13Deal Terms
2Funding, Valuation & Revenue
7 Fundings
Cepheid has raised $58.45M over 7 rounds.
Cepheid's latest funding round was a Grant for $28M on July 30, 2021.
Cepheid's valuation in November 2016 was $4,000M.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
7/30/2021 | Grant | $28M | 1 | |||
11/5/2016 | Acq - P2P | $4,000M | ||||
6/21/2000 | IPO | |||||
1/6/2000 | Series C | |||||
4/13/1998 | Series B |
Date | 7/30/2021 | 11/5/2016 | 6/21/2000 | 1/6/2000 | 4/13/1998 |
|---|---|---|---|---|---|
Round | Grant | Acq - P2P | IPO | Series C | Series B |
Amount | $28M | ||||
Investors | |||||
Valuation | $4,000M | ||||
Revenue | |||||
Sources | 1 |
Cepheid Deal Terms
2 Deal Terms
Cepheid's deal structure is available for 2 funding rounds, including their Acq - P2P from November 05, 2016.
Round | Acq - P2P | Series B |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acq - P2P | |||||||||||||||
Series B |
Cepheid Investors
13 Investors
Cepheid has 13 investors. US Department of Health and Human Services invested in Cepheid's Grant funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
7/30/2021 | 7/30/2021 | 1 Grant | Government | DC | ||
11/5/2016 | 11/5/2016 | 1 Acq - P2P | Corporation | DC | ||
4/13/1998 | 1/6/2000 | 2 Series B, Series C (2000) | Investment Bank | New York | ||
Corporation | Minnesota | |||||
First funding | 7/30/2021 | 11/5/2016 | 4/13/1998 | ||
|---|---|---|---|---|---|
Last Funding | 7/30/2021 | 11/5/2016 | 1/6/2000 | ||
Investor | |||||
Rounds | 1 Grant | 1 Acq - P2P | 2 Series B, Series C (2000) | ||
Board Seats | |||||
Type | Government | Corporation | Investment Bank | Corporation | |
Location | DC | DC | New York | Minnesota |
Cepheid Acquisitions
2 Acquisitions
Cepheid acquired 2 companies. Their latest acquisition was OncoMark on December 16, 2021.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
12/16/2021 | Other | $9.9M | Acquired | 4 | ||
10/3/2014 |
Date | 12/16/2021 | 10/3/2014 |
|---|---|---|
Investment Stage | Other | |
Companies | ||
Valuation | ||
Total Funding | $9.9M | |
Note | Acquired | |
Sources | 4 |
Compare Cepheid to Competitors
Meridian is a life science company involved in the development, manufacturing, marketing, and distribution of diagnostic test kits and reagents. The company provides diagnostic products that are used outside the human body with minimal equipment requirements for the diagnosis of medical conditions such as infections and lead poisoning. Meridian serves hospitals, reference laboratories, research centers, diagnostics manufacturers, and agri-bio companies globally. It was founded in 1977 and is based in Cincinnati, Ohio.
QuantuMDx is a MedTech company focused on multiplex molecular diagnostic solutions within the healthcare sector. The company offers a multiplex PCR testing system that provides results at the Point of Care. QuantuMDx primarily serves healthcare professionals, clinical setting managers, laboratory professionals, and testing providers with its diagnostic products. It was founded in 2008 and is based in Newcastle upon Tyne, England.
DuaTask Solutions provides services aimed at organizing and measuring workload to improve productivity and create accountability in various business sectors. The company primarily serves sectors that require effective workload management and safety protocols. It was founded in 2021 and is based in Clarenville, Canada.
Cypress Medical Products operates in the pharmaceutical and medical supplies distribution sector. The company provides services including the distribution of pharmaceuticals and medical supplies, pharmacy services, and support for oncology and multispecialty solutions. Cypress Medical Products also offers biopharma capabilities, prescription benefit solutions, and consumer products and services to healthcare settings. It was founded in 1988 and is based in Elwood, Illinois.
Roche Diagnostics Automation Solutions focuses on personalized medicine and diagnostics within the healthcare sector. The company offers a range of products and services including the development of personalized medications, diagnostic tests, and digital technologies. Roche primarily serves the healthcare industry, with a focus on delivering therapies and diagnostics. It was founded in 1991 and is based in Ludwigsburg, Germany.
Terumo Europe operates as a healthcare company involved in the production and distribution of medical devices across various sectors. It provides a range of products, including devices for interventional cardiology, oncology, peripheral intervention, cardiovascular surgery, and diabetes care. Its products assist healthcare professionals in diagnosis, treatment, and patient management. It was founded in 1971 and is based in Leuven, Belgium.
Loading...